SHMT2 and colorectal carcinoma: In summary, our current findings demonstrate a novel mechanism by which SHMT2 interacts with and stabilizes β-catenin, thereby promoting the transcription of β-catenin target genes and strengthening CRC cell proliferation and metastasis.